Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3846160 | 0.90 | THRA (0.35) | PLA2G4BTHRATHRB | |
| SCHEMBL3285973 | 0.85 | MAPK14 (0.36) | MAPK14TSHRTHRATHRB | |
| SCHEMBL3841339 | 0.80 | THRA (0.36) | PLA2G4BTHRATHRB | |
| SCHEMBL3841033 | 0.80 | SMPD1 (0.38) | MAPK14TP53TSHRS1PR1S1PR3 | |
| SCHEMBL3841106 | 0.79 | THRA (0.38) | PLA2G4BTHRATHRB | |
| SCHEMBL3842655 | 0.76 | MAPK14 (0.38) | MAPK14TP53TSHRS1PR1S1PR3 | |
| SCHEMBL3291240 | 0.76 | PPARA (0.35) | THRATHRB | |
| SCHEMBL3284699 | 0.74 | THRA (0.36) | PLA2G4BTHRATHRB | |
| SCHEMBL3844912 | 0.71 | PPARG (0.35) | PLA2G4B | |
| SCHEMBL3844829 | 0.70 | SMPD1 (0.39) | MAPK14TP53TSHRS1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1856065-B1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PF MEDICAMENT (FR) | 2009-11-11 | — | — | EP | claimed |